跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
迈达龙 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Dronedarone Hydrochloride Tablets
Approved
化学药品
Dronedarone Hydrochloride Tablets
Sanofi-Aventis U.S. Llc
🇨🇳 National Medical Products Administration
Approval Date
Dec 20, 2021
Approval ID
8DqliMEcZd7
Company
Sanofi-Aventis U.S. Llc
Type
化学药品
Approval Details
Approval Id
8DqliMEcZd7
Approval Number
国药准字HJ20210084
Generic Name
盐酸决奈达隆片
Generic Name En
Dronedarone Hydrochloride Tablets
Brand Name
迈达龙
Drug Type
化学药品
Dosage Form
片剂
Strength
400mg(按C31H44N2O5S计 )
Reg Date
2021-12-20
Expired Date
2026-12-19
Company Name
Sanofi-Aventis U.S. Llc
Production Company Name
SANOFI WINTHROP INDUSTRIE
Company Detail Path
/organization/sanofi-aventis-u-s-llc
Production Company Detail Path
/organization/sanofi-winthrop-industrie
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 20, 2021
Approval ID
8DqliMEcZd7
Type
化学药品
Back to NMPA Approvals